Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
18041
-
18042
Electrochemical, Computational, and Photophysical Characterization of New Luminescent Dirhenium–Pyridazine Complexes Containing Bridging OR or SR Anions
Published 2012“…A series of [Re<sub>2</sub>(μ-ER)<sub>2</sub>(CO)<sub>6</sub>(μ-pydz)] complexes have been synthesized (E = S, R = C<sub>6</sub>H<sub>5</sub>, <b>2</b>; E = O, R = C<sub>6</sub>F<sub>5</sub>, <b>3</b>; C<sub>6</sub>H<sub>5</sub>, <b>4</b>; CH<sub>3</sub>, and <b>5</b>; H, <b>6</b>), starting either from [Re(CO)<sub>5</sub>O<sub>3</sub>SCF<sub>3</sub>] (for <b>2</b> and <b>4</b>), [Re<sub>2</sub>(μ-OR)<sub>3</sub>(CO)<sub>6</sub>]<sup>−</sup> (for <b>3</b> and <b>5</b>), or [Re<sub>4</sub>(μ<sub>3</sub>-OH)<sub>4</sub>(CO)<sub>12</sub>] (for <b>6</b>). …”
-
18043
Electrochemical, Computational, and Photophysical Characterization of New Luminescent Dirhenium–Pyridazine Complexes Containing Bridging OR or SR Anions
Published 2012“…A series of [Re<sub>2</sub>(μ-ER)<sub>2</sub>(CO)<sub>6</sub>(μ-pydz)] complexes have been synthesized (E = S, R = C<sub>6</sub>H<sub>5</sub>, <b>2</b>; E = O, R = C<sub>6</sub>F<sub>5</sub>, <b>3</b>; C<sub>6</sub>H<sub>5</sub>, <b>4</b>; CH<sub>3</sub>, and <b>5</b>; H, <b>6</b>), starting either from [Re(CO)<sub>5</sub>O<sub>3</sub>SCF<sub>3</sub>] (for <b>2</b> and <b>4</b>), [Re<sub>2</sub>(μ-OR)<sub>3</sub>(CO)<sub>6</sub>]<sup>−</sup> (for <b>3</b> and <b>5</b>), or [Re<sub>4</sub>(μ<sub>3</sub>-OH)<sub>4</sub>(CO)<sub>12</sub>] (for <b>6</b>). …”
-
18044
-
18045
Merkel Cell Polyomavirus Small T Antigen Promotes Pro-Glycolytic Metabolic Perturbations Required for Transformation
Published 2016“…While MYC was required for MCT1 induction, MCPyV-induced MCT1 levels decreased following knockdown of the NF-κB subunit RelA, supporting a synergistic activity between MCPyV and MYC in regulating MCT1 levels. …”
-
18046
-
18047
-
18048
-
18049
-
18050
A Family of Binuclear Dysprosium(III) Radical Compounds with Magnetic Relaxation in ON and OFF States
Published 2012“…The adduct ([Dy(hfac)<sub>3</sub>(PyNONIT)]<sub>2</sub>[Dy<sub>0.5</sub>(hfac)<sub>1.5</sub>(H<sub>2</sub>O)]<sub>2</sub>) (<b>3</b>) consists of two items, the dimer [Dy(hfac)<sub>3</sub>(PyNONIT)]<sub>2</sub> and the monomer [Dy(hfac)<sub>3</sub>(H<sub>2</sub>O)<sub>2</sub>], where the symmetry of Dy<sup>III</sup> ion in Dy<sub>2</sub>O<sub>2</sub> decreases to <i>D</i><sub>2<i>d</i></sub>, showing slow relaxation of the magnetization at lower temperature. …”
-
18051
Physiological Markers of Arousal Change with Psychological Treatment for Insomnia: A Preliminary Investigation
Published 2015“…</p><p>Results</p><p>Eight (73%) patients out of 11 consented completed therapy and showed a decrease in insomnia severity pre-to-post treatment (mean (SD): 18.1 (2.8) versus 8.4 (4.8); <i>p</i> = .001). …”
-
18052
-
18053
-
18054
-
18055
-
18056
-
18057
The data of meta-analysis.
Published 2023“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
-
18058
Quality assessment for risk of bias for studies.
Published 2023“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
-
18059
Effect of tirzepatide vs placebo on body weight.
Published 2023“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
-
18060
The results of safety in meta-analysis.
Published 2023“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”